SCHEMBL27939686

SCHEMBL27939686

COC(=O)CCC(CN=[N+]=[N-])NC(=O)OC(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 2/20 0.35
▸ CA1 P00915 1/20 0.35
▸ CA7 P43166 1/20 0.35
▸ CTSK P43235 9/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CA12 O43570 1/20 0.34
▸ CA14 Q9ULX7 1/20 0.34
▸ ATM Q13315 1/20 0.33
▸ CTSS P25774 1/20 0.33
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21480838 1.00 CA2 (0.35) CA2CA1CA7CTSKCYP2D6
SCHEMBL14220437 0.93 CYP2D6 (0.39) CA2CA1CA7CTSKCYP2D6
SCHEMBL28969072 0.88 ATM (0.36) CA2CA1CA7CTSKATM
SCHEMBL28969069 0.88 ATM (0.36) CA2CA1CA7CTSKATM
SCHEMBL29778323 0.86 CYP2D6 (0.40) CA2CA1CA7CTSKCYP2D6
SCHEMBL13633534 0.86 CYP2D6 (0.40) CA2CA1CA7CTSKCYP2D6
SCHEMBL25658173 0.86 CA1 (0.42) CA2CA1CA7CTSKCYP2D6
SCHEMBL24629628 0.85 CTSK (0.36) CA2CA1CA7CTSKCYP2D6
SCHEMBL27696913 0.85 CTSK (0.43) CA2CA1CA7CTSKCTSS
SCHEMBL14496983 0.85 CTSK (0.37) CA2CA1CA7CTSKCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103351389-A Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith SIGNAL PHARM LLC 2013-10-16 — — CN disclosed
CN-101478972-A Haloaryl substituted aminopurines, compositions thereof, and methods of using same in therapy SIGNAL PHARM LLC (US) 2009-07-08 — — CN disclosed
Send feedback